Bio

Tony Chan practice focuses on advising companies and investors in the life sciences and tech sectors on strategic domestic and cross-border corporate transactions. Tony regularly advises clients on mergers and acquisitions (M&A), private equity, growth equity, and venture capital transactions, as well as on corporate governance, joint ventures and corporate finance. His clients include global strategic buyers and sellers, as well as financial sponsors and their portfolio companies in the life science, healthcare, investment management, technology and video game industries. Tony has been recognized for his life sciences and M&A work by a number of notable publications, including The Legal 500 US, Law360, IFLR1000 and Legal Media Group. In particular, Law360 highlighted his work in navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies. In addition, Tony sustains an active pro bono practice, serving as counsel to nonprofit organizations such as Aequitas, APAI Vote, Rebuilding Together Philadelphia, the Philadelphia Film Society, and the Harvard Asian Alumni Alliance, as well as several charter schools, including Rocketship Education. Tony also serves as an adjunct professor at Georgetown Law School where he taught Takeovers, Mergers and Acquisitions since 2015.